Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Genmab reported DKK28.23B in Current Assets for its fiscal quarter ending in March of 2023.

Current Assets Change
Agios Pharmaceuticals AGIO:US USD 791.66M 41.12M
Almirall SA ALM:SM EUR 552.72M 11.07M
Amarin AMRN:US USD 683.82M 5.28M
Amgen AMGN:US USD 44.7B 22.52B
Artemis Alpha ATS:LN GBP 4.91M 719K
AstraZeneca AZN:LN USD 22.27B 327M
Bayer BAYN:GR EUR 39.62B 1.86B
BioMarin Pharmaceutical BMRN:US USD 2.84B 90.65M
Bluebird Bio BLUE:US USD 351.07M 151.58M
Demant A/s WDH:DC DKK 10.02B 96M
Exelixis EXEL:US USD 1.64B 18.86M
Galapagos GLPG:NA EUR 4.16B 81.56M
Genmab GEN:DC DKK 28.23B 146M
GlaxoSmithKline GSK:LN GBP 19.72B 1.05B
GN Store Nord GN:DC DKK 8.73B 637M
Hikma Pharmaceutical HIK:LN USD 2B 145M
Immunogen IMGN:US USD 243.86M 60.26M
Insmed INSM:US USD 1.13B 144.32M
Lonza Group LONN:SW CHF 5.72B 13M
Merck MRK:GR EUR 12.95B 750M
Novartis NOVN:VX USD 32.11B 4.8B
Regeneron Pharmaceuticals REGN:US USD 16.91B 1.03B
Roche Holding ROG:VX CHF 33.82B 3.5B
Seattle Genetics SGEN:US USD 2.6B 200.62M